| Stage | MKC | % of rev | HP | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $2.0B | 100.00% | $1.0B | 100.00% | MKC ×1.96 |
| Gross profit | $795M | 39.26% | $305M | 29.52% | MKC +9.7pp |
| Operating income | $217M | 10.72% | $188M | 18.19% | HP +7.5pp |
| Pre-tax income | $155M | 7.63% | $151M | 14.54% | HP +6.9pp |
| Net income | $108M | 5.31% | $78M | 7.55% | HP +2.2pp |
| Stage | MKC | HP | Gap · A − B |
|---|---|---|---|
| Revenue | $2.0B100.00% | $1.0B100.00% | MKC ×1.96 |
| Gross profit | 39.26%$795M | 29.52%$305M | MKC +9.7pp |
| Operating income | 10.72%$217M | 18.19%$188M | HP +7.5pp |
| Pre-tax income | 7.63%$155M | 14.54%$151M | HP +6.9pp |
| Net income |
| 5.31%$108M |
| 7.55%$78M |
| HP +2.2pp |
No shared counterparties.